X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results Transcript - Thomson StreetEvents

X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results Transcript

X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results Transcript - Thomson StreetEvents
X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results Transcript
Published Nov 29, 2022
Published Nov 29, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of XFOR.OQ conference call or presentation 29-Nov-22 9:30pm GMT

  
Report Type:

Transcript

Source:
Company:
X4 Pharmaceuticals Inc
Ticker
XFOR.OQ
Time
9:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

X4 Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-13 – US$ 54.00 – Edited Transcript of XFOR.OQ presentation 13-Sep-23 11:30am GMT

X4 Pharmaceuticals Inc Q2 2023 Earnings Call Transcript – 2023-08-10 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 10-Aug-23 12:30pm GMT

X4 Pharmaceuticals Inc 4WHIM Phase 3 Clinical Trial Update Call Transcript – 2023-05-16 – US$ 54.00 – Edited Transcript of XFOR.OQ conference call or presentation 16-May-23 8:00pm GMT

X4 Pharmaceuticals Inc Q1 2023 Earnings Call Transcript – 2023-05-04 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 4-May-23 12:30pm GMT

X4 Pharmaceuticals Inc Q4 2022 Earnings Call Transcript – 2023-03-21 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 21-Mar-23 1:00pm GMT

X4 Pharmaceuticals Inc at Stifel Healthcare Conference Transcript – 2022-11-15 – US$ 54.00 – Edited Transcript of XFOR.OQ presentation 15-Nov-22 8:00pm GMT

X4 Pharmaceuticals Inc Q3 2022 Earnings Call Transcript – 2022-11-03 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 3-Nov-22 12:30pm GMT

X4 Pharmaceuticals Inc at Canaccord Genuity Growth Conference Transcript – 2022-08-11 – US$ 54.00 – Edited Transcript of XFOR.OQ presentation 11-Aug-22 7:30pm GMT

X4 Pharmaceuticals Inc Q2 2022 Earnings Call Transcript – 2022-08-04 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 4-Aug-22 12:30pm GMT

X4 Pharmaceuticals Inc Q1 2022 Earnings Call Transcript – 2022-05-12 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 12-May-22 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results Transcript" Nov 29, 2022. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/X4-Pharmaceuticals-Inc-To-Discuss-Key-Top-Line-4WHIM-Trial-Results-T15413338>
  
APA:
Thomson StreetEvents. (2022). X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results Transcript Nov 29, 2022. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/X4-Pharmaceuticals-Inc-To-Discuss-Key-Top-Line-4WHIM-Trial-Results-T15413338>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.